Review of haemophagocytic lymphohistiocytosis

Archives of Disease in Childhood

Volumn 96, Issue 7, 2011, Pages 688-693

  Freeman, H R ^a   Ramanan, A V ^a  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN;

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BLOOD CLOTTING DISORDER; CHEDIAK HIGASHI SYNDROME; CLINICAL FEATURE; CONSANGUINITY; CYTOTOXIC LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EXOCYTOSIS; FAMILIAL DISEASE; FAMILY HISTORY; FEVER; GENE MUTATION; GENETIC ASSOCIATION; GRISCELLI SYNDROME; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LEUKEMIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MACROPHAGE ACTIVATION SYNDROME; MYCOSIS; NATURAL KILLER CELL; OCULAR ALBINISM; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVIEW; SEPSIS; THROMBOCYTOPENIA; VIRUS INFECTION; X CHROMOSOME LINKED DISORDER;

ALGORITHMS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FERRITINS; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PRACTICE GUIDELINES AS TOPIC;

EID: 79953007434     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.176610     Document Type: Review

References (62)

1. Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Dis Child 1952;27:519-25.
2. Enders A, Zieger B, Schwarz K, et al. Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. Blood 2006;108:81-7. (Pubitemid 43990615)
3. Henter JI, Elinder G, Söder O, et al. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991;80:428-35.
4. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999;286:1957-9. (Pubitemid 129515904)
5. Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr 2009;221:278-85.
6. Ohadi M, Lalloz MR, Sham P, et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet 1999;64:165-71. (Pubitemid 30428969)
7. Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003;115:461-73. (Pubitemid 37456808)
8. zur Stadt U, Schmidt S, Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 2005;14:827-34.
9. Zur Stadt U, Beutel K, Kolberg S, et al. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat 2006;27:62-8. (Pubitemid 43042967)
10. Côte M, Ménager MM, Burgess A, et al. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest 2009;119:3765-73.
11. Henter JI, Elinder G, Söder O, et al. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-22.
12. Jordan MB, Hildeman D, Kappler J, et al. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 2004;104:735-43. (Pubitemid 38970567)
13. Duval M, Fenneteau O, Doireau V, et al. Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr 1999;134:236-9. (Pubitemid 29089052)
14. Nagafuji K, Nonami A, Kumano T, et al. Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica 2007;92:978-81. (Pubitemid 350144246)
15. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 2007;166:95-109. (Pubitemid 46025500)
16. Fisman DN. Hemophagocytic syndromes and infection. Emerging Infect Dis 2000;6:601-8. (Pubitemid 32110502)
17. Henter JI, Ehrnst A, Andersson J, et al. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr 1993;82:369-72. (Pubitemid 23142852)
18. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002;44:259-72. (Pubitemid 35435291)
19. Kawaguchi H, Miyashita T, Herbst H, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993;92:1444-50. (Pubitemid 23273923)
20. Dolezal MV, Kamel OW, van de Rijn M, et al. Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. Am J Clin Pathol 1995;103:189-94.
21. Janka G, Henter J, Imashuku S. Clinical aspects and therapy of hemophagocytic lymphohistiocytosis. In: Weitzman S, Egeler R, eds. Histiocytic disorders of children & adults. 1st edn. Cambridge: Cambridge University Press, 2005:353-79.
22. Titze U, Janka G, Schneider EM, et al. Hemophagocytic lymphohistiocytosis and Kawasaki disease: combined manifestation and differential diagnosis. Pediatr Blood Cancer 2009;53:493-5.
23. Ramanan AV, Wynn RF, Kelsey A, et al. Systemic juvenile idiopathic arthritis, Kikuchi's disease and haemophagocytic lymphohistiocytosis - is there a link? Case report and literature review. Rheumatology (Oxford) 2003;42:596-8. (Pubitemid 36432481)
24. Stéphan JL, Koné-Paut I, Galambrun C, et al. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001;40:1285-92.
25. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6. (Pubitemid 33702300)
26. Behrens EM, Beukelman T, Paessler M, et al. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007;34:1133-8. (Pubitemid 46774861)
27. Prahalad S, Bove KE, Dickens D, et al. Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 2001;28:2120-4. (Pubitemid 32803794)
28. Makay B, Yilmaz S, Türkyilmaz Z, et al. Etanercept for therapy-resistant macrophage activation syndrome. Pediatr Blood Cancer 2008;50:419-21.
29. Takahashi N, Naniwa T, Banno S. Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome. Mod Rheumatol 2008;18:72-5.
30. Aouba A, De Bandt M, Aslangul E, et al. Haemophagocytic syndrome in a rheumatoid arthritis patient treated with infliximab. Rheumatology (Oxford) 2003;42:800-2. (Pubitemid 37220916)
31. Ramanan AV, Schneider R. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol 2003;30:401-3. (Pubitemid 36152611)
32. Doyle T, Bhagani S, Cwynarski K. Haemophagocytic syndrome and HIV. Curr Opin Infect Dis 2009;22:1-6.
33. Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31. (Pubitemid 44958267)
34. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004;124:4-14. (Pubitemid 38021618)
35. Suzuki N, Morimoto A, Ohga S, et al. Characteristics of hemophagocytic lymphohistiocytosis in neonates: a nationwide survey in Japan. J Pediatr 2009;155:235-8.e1.
36. Dinarello CA. Cytokines as endogenous pyrogens. J Infect Dis 1999;179(Suppl 2):S294-304.
37. Otterbein LE, Soares MP, Yamashita K, et al. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003;24:449-55. (Pubitemid 36928103)
38. Henter JI, Elinder G. Cerebromeningeal haemophagocytic lymphohistiocytosis. Lancet 1992;339:104-7.
39. Rooms L, Fitzgerald N, McClain KL. Hemophagocytic lymphohistiocytosis masquerading as child abuse: presentation of three cases and review of central nervous system findings in hemophagocytic lymphohistiocytosis. Pediatrics 2003;111:e636-40.
40. Lowe LH, Fernando S, Obaldo R, et al. Duplicate publication with consequence of potential misinformation and further controversy. Pediatr Radiol 2008;38:839-40.
41. Hansen K, Frikke M. Dual and discrepant case publication in regard to hemophagocytic lymphohistiocytosis and child abuse. Pediatr Radiol 2007;37:846. (Pubitemid 47097434)
42. Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 2009;10:387-92.
43. Schneider EM, Lorenz I, Müller-Rosenberger M, et al. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood 2002;100:2891-8.
44. Horne A, Zheng C, Lorenz I, et al. Subtyping of natural killer cell cytotoxicity deficiencies in haemophagocytic lymphohistocytosis provides therapeutic guidance. Br J Haematol 2005;129:658-66. (Pubitemid 40825828)
45. Bryceson YT, Rudd E, Zheng C, et al. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 2007;110:1906-15. (Pubitemid 47443904)
46. Bleesing J, Prada A, Siegel DM, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007;56:965-71. (Pubitemid 46399444)
47. Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008;50:1227-35. (Pubitemid 351555548)
48. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983;140:221-30. (Pubitemid 13026976)
49. Janka G, Imashuku S, Elinder G, et al. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:435-44. (Pubitemid 28175891)
50. Henter JI, Samuelsson-Horne A, Aricò M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002;100:2367-73.
51. Horne A, Janka G, Maarten Egeler R, et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005;129:622-30. (Pubitemid 40825824)
52. Mahlaoui N, Ouachée-Chardin M, de Saint Basile G, et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics 2007;120:e622-8.
53. Pachlopnik Schmid J, Ho CH, Chrétien F, et al. Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Mol Med 2009;1:112-24.
54. Cooper N, Rao K, Goulden N, et al. The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone Marrow Transplant 2008;42(Suppl 2):S47-50.
55. Baker KS, Filipovich AH, Gross TG, et al. Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 2008;42:175-80.
56. Cooper N, Rao K, Gilmour K, et al. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood 2006;107:1233-6. (Pubitemid 43156331)
57. Ouachée-Chardin M, Elie C, de Saint Basile G, et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics 2006;117:e743-50.
58. Jordan MB, Filipovich AH. Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step. Bone Marrow Transplant 2008;42:433-7.
59. Imashuku S, Kuriyama K, Sakai R, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol 2003;41:103-9. (Pubitemid 36858327)
60. Stéphan JL, Donadieu J, Ledeist F, et al. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 1993;82:2319-23. (Pubitemid 23304254)
61. Milone MC, Tsai DE, Hodinka RL, et al. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood 2005;105:994-6. (Pubitemid 40170866)
62. Ramanan A, Laxer R, Schneider R. Secondary haemophagocytic syndromes associated with rheumatic diseases. In: Weitzman S, Egeler R, eds. Histiocytic disorders of children & adults. 1st edn. Cambridge: Cambridge University Press, 2005:380-95.